baber/WOPTO huggingface dataset:
Patent CA-2578099-A1 (CA)
Title: Rfid sensor array
Inventor: SULLIVAN MICHAEL S
IPC: G06K7/00
Filed: 2005-08-16
Abstract: An RFID performance monitoring system may include systems, methods, or computer program products for collecting information related to the performance of an RFID system. One source of performance-related information can be the RFID readers, both during an active (reading) period and an inactive (listening) period. In various embodiments described herein, a performance monitoring system may collect performance-related information from RFID readers during both during their active and inactive periods.
Patent CA-2578351-A1 (CA)
Inventor: INADA YUUICHI
IPC: C09K3/18
Filed: 2005-06-24
Abstract: A surface-treating agent which comprises: (A) an acrylic resin having a hydrolyzable silyl group, hydroxy group, and polysiloxane chain; (B) an organopolysiloxane having a hydrolyzable silyl group; and (C) an organopolysiloxane having no hydrolyzable silyl group.
Patent CA-2578473-A1 (CA)
Title: Peptide nucleic acid conjugates and uses thereof
Inventor: ECCLES ROGER MICHAEL
IPC: A61K38/00
Filed: 2004-10-15
Abstract: The invention provides a triphenylphosphonium peptide nucleic acid conjugate.  The conjugate comprises a peptide nucleic acid linked via a disulfide bond, to a triphenylphosphonium group. Conjugates of the invention can be used to deliver PNA oligomers across the plasma membrane into cells.
Patent CA-2579259-A1 (CA)
Title: Key agreement and transport protocol with implicit signatures
Inventor: MENEZES ALFRED JOHN
IPC: H04L9/32
Filed: 1996-04-16
Abstract: A key establishment protocol between a pair of correspondents includes the generation by each correspondent of respective signatures. The signatures are derived from information that is private to the correspondent and information that is public. After exchange of signatures, the integrity of exchange messages can be verified by extracting the public information contained in the signature and comparing it with information used to generate the signature. A common session key may then be generated from the public and private information of respective ones of the correspondents.
Patent CA-2580985-A1 (CA)
Inventor: RENZETTI DANIEL
IPC: A01L7/04
Filed: 2007-03-08
Abstract: A horseshoe stud with a head and a shaft having a plurality of ribs formed thereon and extending at least partially circumferentially around the shaft. Preferably, the ribs have a frustro-conical shape. The stud according to the present invention can be simply installed in a stud hole by using a punch like device, the stud is installed in a stud hole located on the punch and an impact is given by way of an impacting tool so as to to drive said stud into a predrilled hole made into a shoe. This installation is much easier to carry out compared to the installation of prior art drive-in studs having smooth shafts.
Patent CA-2581659-A1 (CA)
Inventor: SAETTI RICCARDO
IPC: G09B5/06
Filed: 2005-09-13
Abstract: The present invention concerns a system of delivering interactive seminars that allows, in particular, the projection of interactive movies, enjoyed by groups of people attending the seminars with the possible supervision of a tutor, apt to modify their own story depending on decisions and behaviours of the audience, the system stimulating the attention of the participants through the stimulus of all the sensory channels controlling the learning process, ensuring a strong involvement of the participants with the maximum reproducibility of the instructive results, the system being extremely efficient, reliable, and simple to use. The present invention further concerns the related method of delivering interactive seminars, and the instruments and the apparatuses of the system.
Patent CA-2582236-A1 (CA)
Title: Tumor models employing green fluorescent protein
Inventor: QING WEIGUO
IPC: C12N5/10
Filed: 2007-03-27
Abstract: The present invention relates to a method of evaluating whether a tumor metastasizes, a method for evaluating a candidate drug or protocol for the inhibition of metastasis of a tumor, a method for evaluating a candidate drug or protocol for the treatment of a tumor and a method of enhancing the propensity of a cell line to metastasize to a particular tissue. The invention also relates to a new LOX-GFP-LM cell line.
Patent CA-2582752-A1 (CA)
Inventor: BEDOS-BELVAL FLORENCE
IPC: C07F9/42
Filed: 2005-09-26
Abstract: The invention concerns a method for specifically fluorinating a phosphorus atom of a phosphonocinnamic compound of general formula (II) or (II'), wherein: X is selected among: an oxygen atom, a sulphur atom; R1, R2, R3, R4, R5 and R6 being selected among H, an alkyl group, an aryl group, OH, O-alkyl, S-alkyl, NH2, NH-alkyl, N-(alkyl)2 group; R7 being selected among: H, an alkyl group, an aryl group, a silyl group; R8 being selected among: H, an alkyl group, an aryl group; TBDPS representing a t-butyldiphenylsilyl group. Said method consists in reacting said compound with a fluorinating agent comprising a complex formed between a tertiary amine and hydrogen fluoride. The invention also concerns novel fluorinated compounds thus prepared, as well as therapeutic compositions comprising such fluorinated compounds, and their uses for treating atherosclerosis.
Patent CA-2583881-A1 (CA)
Inventor: GOODBRAND H BRUCE
IPC: C07F7/18
Filed: 2007-04-04
Abstract: Methods are provided for preparing reactive silane ester compounds, such as aromatic reactive silane ester compounds. The methods include providing a carboxylic, acid-containing starting material, reacting the carboxylic acid-containing starting material with a base to form a salt, and reacting the salt with a halo-alkylene-silane to form a reactive silane ester compound. Compositions prepared by these methods, protective layers that include hydrolysis and condensation products of such compositions, electrophotographic photoreceptors that include such protective layers, and image forming apparatuses that include such electrophotographic photoreceptors are also provided.
Patent CA-2587524-A1 (CA)
Title: Substituted benzoquinolizine derivates
Inventor: BOEHRINGER MARKUS
IPC: A61K31/4745
Filed: 2005-11-21
Abstract: The present invention relates to compounds of formula (I); wherein R1 to R4 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with DPP-IV, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance.
Patent CA-2588602-A1 (CA)
Title: Wind turbine
Inventor: JONSSON STANLEY
IPC: B63H1/06
Filed: 2005-11-23
Abstract: A wind turbine, with: a rotatable frame; a plurality of airfoils mounted to the rotatable frame, wherein the airfoils extend parallel to an axis of rotation of the rotatable frame; a wind block positioned to restrict airflow over at least a portion of the rotatable frame; and at least one drive wheel in contact with the rotatable frame.
Patent CA-2591433-A1 (CA)
Inventor: MATTHEWS DAVID R
IPC: C10J3/50
Filed: 2007-06-11
Abstract: A pump for transporting particulate material includes an inlet, an outlet, a passageway, a first and second load beam, a first and second scraper seal, and a first and second drive assembly. The inlet introduces the particulate material into the passageway and the outlet expels the particulate material from the passageway. The passageway is defined by a first belt assembly and a second belt assembly that are opposed to each other. The first and second load beams are positioned within the first belt assembly and the second belt assembly, respectively. The first scraper seal and a second scraper seal are positioned proximate the passageway and the outlet. The first drive assembly is positioned within an interior section of the first belt assembly and drives the first belt assembly and the second drive assembly is positioned within an interior section of the second belt assembly and drives the second belt assembly.
Patent CA-2592925-A1 (CA)
Inventor: YUI GEORGE
IPC: B67D1/07
Filed: 2007-07-03
Abstract: The present invention is a bottled water cooler with a hot water sterilization system. A bottled water cooler with a hot water sterilizing system having a cold tank installed on the top of the cooler. There is a bottle receptacle in it, and the bottle receptacle groove having a probe connecting with water bottle and the cold tank inside. There is a baffle on a hollow baffle leader under the probe. The end of the baffle leader connects with a hot tank installed under cold tank by the cold and hot tank connecting tube, hot tank draining three-way pipe or draining pipe.
Patent CA-2595398-A1 (CA)
Inventor: ROM ERAN
IPC: A61K39/395
Filed: 2005-11-03
Abstract: The present invention generally relates to a pharmaceutical composition and to an improved method of preventing, attenuating and treating multiple myeloma (MM) by administering to an individual in need thereof at least one antibody to fibroblast growth factor receptor 3 (FGFR3). In particular, the at least one FGR3 antibody induces apoptosis of myeloma cells expressing wild type FGFR3.
Patent CA-2595552-A1 (CA)
Inventor: YU JISANG
IPC: H01M6/16
Filed: 2006-02-13
Abstract: L'invention concerne une batterie secondaire au lithium utilisant une cathode contenant un oxyde métallique de transition contenant du lithium et une anode contenant un carbone graphité. Le composé d'ammonium, qui peut fournir des ions d'ammonium, est ajouté à un électrolyte non aqueux. L'invention concerne donc une batterie secondaire au lithium présentant une performance améliorée à température élevée, les baisses de capacité résiduelle et de capacité de récupération étant réduites du fait du stockage à température élevée de la batterie, grâce à l'adjonction d'un tel composé d'ammonium.
Patent CA-2601749-A1 (CA)
Title: A process for large-scale production of cdte/cds thin film solar cells, without the use of cdc12
Inventor: ROMEO ALESSANDRO
IPC: H01L31/18
Filed: 2006-02-02
Abstract: A process for the large-scale production of CdTe/CdS thin film solar cells, said films being deposited as a sequence on a transparent substrate, comprising the steps of : depositing a film of a transparent conductive oxide (TCO) on said substrate; depositing a film of CdS on said TCO film; depositing a film of CdTe on said CdS film; treating said CdTe film with a Chlorine-containing inert gas; depositing a back-contact film on said treated CdTe film. The Chlorine -containing inert gas is a Chlorof luorocarbon or a Hydrochlorof luorocarbon product and the treatment is carried out in a vacuum chamber at an operating temperature of 380-4200C. The Chlorine released as a result of the thermal dissociation of the product reacts with solid CdTe present on the cell surface to produce TeCl2 and CdCl2 vapors. Any residual CdCl2 is removed from the cell surface by applying vacuum to the vacuum chamber while keeping the temperature at the operating value.
Patent CA-2604229-A1 (CA)
Title: Apparatus for controlling a downhole device
Inventor: PURKIS DANIEL
IPC: E21B43/12
Filed: 2006-05-12
Abstract: Apparatus for controlling a downhole device such as a choke, the apparatus comprising a housing (1), a mandrel (5) connected to the downhole device and moveable within the housing to move the device between different positions, and a detent mechanism to selectively lock the mandrel in one of the positions within the housing. The first and second positions are typically defined by physical stops on the apparatus such as shoulders, or dogs and grooves etc, and are typically placed at set positions that define the different configurations of the device. Thus, the movement of the downhole device is governed by the detent mechanism, rather than by variable factors such as pressure changes .
Patent CA-2604916-A1 (CA)
Title: Dihydrobenzofuran derivatives and uses thereof
Inventor: TALAAT RASMY ELSAYED
IPC: A61P25/00
Filed: 2006-04-21
Abstract: Compounds of formula (I) are described herein which are agonists or partial agonists of the 2C subtype of brain serotonin receptors. Formula (I), or pharmaceutically acceptable salts thereof, wherein each of R1, R2, R3, R4, Rx, Ry, and n are as defined herein. Such compounds, and compositions thereof, are useful for treating a variety of central nervous system disorders such as schizophrenia.
Patent CA-2606086-A1 (CA)
Inventor: JAMIESON GENE C
IPC: A61K31/23
Filed: 2006-04-25
Abstract: Described here are TRPVl agonist compounds and their methods of synthesis and use. In addition to specifically identified compounds, capsaicin prodrugs, gemini dimers, and mutual prodrugs are also described. Formulations of the TRPVl agonist compounds may be in the form of a liquid, tablets, capsules, gel, cream, emulsion, a patch, or the like. Methods for treating medical conditions using the compounds, compositions, or prodrugs described, are also provided.
Patent CA-2606816-A1 (CA)
Title: Implant dentaire a structure poreuse trabeculaire
Inventor: CATERINI RICHARD
IPC: A61K6/04
Filed: 2005-05-04
Abstract: L'invention concerne un implant dentaire comportant un massif poreux biocompatible dans lequel est aménagé au moins un alésage de réception (8) pour une pièce de liaison d'une prothèse dentaire, caractérisé en ce que le massif poreux biocompatible (2) est constitué par un unique matériau à  structure trabéculaire assurant une communication entre l'extérieur dudit massif poreux et l'intérieur dudit massif poreux.
Patent CA-2607830-A1 (CA)
Inventor: COOK ROBERT LANCE
IPC: E21B17/00
Filed: 2000-03-07
Abstract: An apparatus is provided which includes first and second tubular members, wherein the inner diameter of the first tubular member is substantially equal to the inner diameter of the second tubular member, and the first and second tubular members are coupled by the process of deforming a portion of the second tubular member into contact with a portion of the fust tubular member. Also provided is a method for forming a wellbore by the process of drilling the wellbore, wherein a tubular liner is positioned within the wellbore and formed by the process of extruding the tubular liner off of a mandrel while drilling the wellbore.
Patent CA-2609656-A1 (CA)
Inventor: SCHNEIDER GERALD
IPC: A61K38/08
Filed: 2006-04-25
Abstract: Compositions that include nanoscale structured materials or precursors thereof (e.g., self-assembling peptides) are described. The compositions can include other substances (e.g., a vasoconstrictor). Also described are methods for using the compositions to promote hemostasis, to protect the skin or wounds from contamination, to decontaiminate a site upon removal of previously applied compositions that provided a protective coating, and to inhibit the movement of bodily substances other than blood. The compositions are also useful in isolating tissue, removing tissue, preserving tissue (for, e.g., subsequent transplantation or reattachment), and as bulking, stabilizing or hydrating agents. Medical devices that include the compositions (e.g., a stent or catheter), bandages or other wound dressings, sutures, and kits that include the compositions are also described.
Patent CA-2611970-A1 (CA)
Title: Dispositif de direction a encombrement reduit pour atterrisseur d'aeronef
Inventor: DE RUFFRAY PAUL
IPC: B64C25/50
Filed: 2006-06-22
Abstract: - L'objet de l'invention est un dispositif de direction pour atterrisseur (1 ) d'aéronef caractérisé en ce qu'il comporte au moins un moyen de manAEuvre en rotation (2, 3, 4, 5) des roues (6) de l'atterrisseur disposé le long de la jambe (13) de l'atterrisseur
Patent CA-2612489-A1 (CA)
Inventor: GHASSABIAN FIROOZ
IPC: G06F3/038
Filed: 2006-06-16
Abstract: A data entry system, for processing ambiguous data, as shown in Figure 18 includes unambiguous keys (14207, 14208) and ambiguous keys (14203). The system predicts words from the ambiguous entry. If the predicted word is not desired, an unambiguous entry replaces a character in the word with the desired character. A second prediction is made based on the unambiguous entry.
Patent CA-2612609-A1 (CA)
Inventor: KASAHARA AKIRA
IPC: B65B13/28
Filed: 2006-06-28
Abstract: La présente invention concerne un dispositif pour détecter une tension d~alimentation au cours d~une étape de torsion du câble de raccordement soumis à la charge la plus lourde et à comparer une tension d~alimentation avec une tension d~exploitation d~une CPU connue, et un dispositif de commande pour entraîner un moteur à tourner dans le sens inverse lorsqu~une tension chute au dessous d~une tension d~exploitation de la CPU connue et à replacer un mécanisme de torsion d~un câble de raccordement en position initiale. Du fait qu~une tension d~alimentation au cours d~une opération est surveillée et qu~une opération de torsion est suspendue avant que la tension ne chute en dessous de la tension d~exploitation d~une CPU connue pour rétablir le mécanisme de torsion de câble de raccordement à une position initiale, l~arrêt du mécanisme de torsion du câble de raccordement est empêché tandis qu~il serre les câbles de raccordement lorsque la CPU s~arrête.
Patent CA-2614162-A1 (CA)
Inventor: LU ED YILING
IPC: A61K47/30
Filed: 2007-12-13
Abstract: The present invention provides a method of using locally administered collagenase as a non-invasive means of enhancing cell release from the cartilage or fibrocartilage tissues adjacent to a disease or injury site. The subsequent migration of cells from these tissues into the lesion or wound, followed by deposition of the appropriate extracellular matrix, results in closure of the lesion or fusion of a tissue gap.
Patent CA-2621724-A1 (CA)
Title: System gaming
Inventor: CROWDER ROBERT W JR
IPC: G06Q50/00
Filed: 2006-09-07
Abstract: A method provides a player tracking system and system gaming apparatus for playing non-base games by funding the credit side of a gaming cycle. The system further includes at least one gaming device having a base game. The player tracking system and system gaming apparatus includes a player tracking user interface. The player tracking user interface provides a player with an opportunity to select and play a non-base game that may be promotional-funded or player-funded.
Patent CA-2623195-A1 (CA)
Title: Novel wax-like polymer for use in hot melt adhesive applications
Inventor: BORSINGER GREGORY
IPC: C09J123/08
Filed: 2006-09-21
Abstract: Adhesives comprising one or more tackifiers, ethylene vinyl acetate copolymers ("EVA") and a low viscosity, low number average molecular weight (Mn between 700 and less than 1000) ethylene/alpha-olefin interpolymer which has wax-like properties, and produced using a single metallocene catalyst system, were formulated, and have adhesive characteristics over a broad temperature range.  These hot melt adhesive compositions ("HMAs") have properties comparable to those of commercially available, three component HMAs comprising ethylene vinyl acetate polymers, tackifÊer and wax. HMA embodiments include those wherein the ethylene/alpha-olefin interpolymers comprise ethylene and propylene as copolymers, and the interpolymer has a low Brookfield viscosity, between 20 - 50 centipoise at 300~F.
Patent CA-2624491-A1 (CA)
Title: Novel azetidine compounds useful in the treatment of functional gastrointestinal disorders, ibs and functional dyspepsia
Inventor: BERGMAN ROLF
IPC: A61K31/5383
Filed: 2006-09-27
Abstract: The present invention relates to new azetidine compounds, to pharmaceutical compositions cotaining them and the use of said compounds in in the treatment of functional gastrointestinal disorders, IBS and functional dyspepsia. The compounds are neurokinin (NK) antagonists . The present invention further relates to processes for the preparation of the compounds.
Patent CA-2625619-A1 (CA)
Inventor: WU HERREN
IPC: C07K16/46
Filed: 2006-10-13
Abstract: The present invention relates to a viral vector encoding for a library of antibodies or antibody fragments that are displayed on the cell membrane when expressed in a cell. The present invention provides cells comprising the viral vector nucleic acids and methods of screening the libraries for antibodies or antibody fragments with desired characteristics.
Patent CA-2625778-A1 (CA)
Inventor: ATTINGER JUERG
IPC: A61F9/007
Filed: 2008-03-14
Abstract: A cannula having a tube that is longitudinally split and open along the entire, or along substantially the entire, length of the tubing. Attached to the proximal end of the tubing is a hub that is also longitudinally split and open. The hub acts as a stop to prevent the entire cannula from entering the incision.
Patent CA-2626489-A1 (CA)
Title: Materials and methods for respiratory disease control in canines
Inventor: GOOVAERTS DANIEL GHISLENA EMIE
IPC: A61K39/00
Filed: 2006-10-19
Abstract: The subject invention pertains to isolated influenza virus that is capable of infecting canids and causing respiratory disease in the canid. The subject invention also pertains to compositions and methods for inducing an immune response against an influenza virus of the present invention. The subject invention also pertains to compositions and methods for identifying a virus of the invention and diagnosing infection of an animal with a virus of the invention.
Patent CA-2626724-A1 (CA)
Inventor: MARLY PASCAL
IPC: F02C7/22
Filed: 2008-03-19
Abstract: The device has control chambers (62, 64) of a cylinder (60) connected with usage outlets (U1, U2) of a hydraulic distributor (20) with low pressure or high pressure. Bearings (54, 56) of a slide (52) of an actuator e.g. fuel metering valve (50), are subjected to the high and low pressures on two sides of the bearing respectively. A dynamic seal (70) assures sealing between the bearings and the cylinder, where the seal produces dynamic friction between the bearing and the cylinder based on a difference between the pressures on the sides of the bearing.
Patent CA-2627162-A1 (CA)
Inventor: SHAUB HAROLD
IPC: C10M125/18
Filed: 2006-10-20
Abstract: A lubricant additive produced by the process comprising mixing an organophosphate and an organofluorine compound and reacting the organophosphate and the organofluorine compound to produce a reaction mixture comprising the lubricant additive. Also, a lubricant produced by the process comprising forming a reaction mixture by reacting an organophosphate and an organofluorine and adding at least a portion of the reaction mixture to a lubricant base.
Patent CA-2628347-A1 (CA)
Inventor: TIMPEL DAVID K
IPC: B67D1/08
Filed: 2008-04-04
Abstract: A beverage dispenser has a faucet with a spout, a fitting for connection to a beverage supply, and a lever operated valve. A servo motor, coupled to the lever, operates the faucet and proportionally controls the flow of the beverage. That proportional flow control manages the amount of beverage foaming. A flow sensor has a magnetic turbine within the faucet and a Hall effect element that magnetically senses turbine motion and produces a signal indicating an amount of beverage flow. A keypad enables service personnel to designate various portions of the beverage to automatically fill serving containers of different sizes. A control circuit responds to activation of the keypad and to the flow sensor by operating the servo motor to dispense the related quantity of the beverage.
Patent CA-2629244-A1 (CA)
Inventor: BAUM ANKE
IPC: A61K31/517
Filed: 2006-11-09
Abstract: The present invention relates to the use of quinazolines of formula (I), wherein the groups Ra to Rd have the meanings given in the claims and specification, in cancer therapy.